NEWS
WorldCare Clinical, a leader in medical imaging and event adjudication solutions for clinical trials announces a series of leadership appointments
BOSTON (PRWEB) DECEMBER 07, 2022 WorldCare Clinical, a leader in medical imaging and event adjudication solutions for clinical trials announces the most recent expansion of its
WORLDCARE CLINICAL ACQUIRES LEADING OPHTHALMOLOGY IMAGING CORE LAB
Boston, MA, September 3, 2021 – WorldCare Clinical (WCC), a global imaging core lab, has acquired New York-based Digital Angiography Reading Center (DARC), the world’s leading
WORLDCARE CLINICAL COMMENCES INDEPENDENT REVIEW OF LARGE PHASE III MELANOMA TRIAL
Boston, MA, March 15, 2021 — WorldCare Clinical (WCC), a leading provider of imaging services in Oncology clinical trials, today announced that it had commenced
WORLDCARE CLINICAL COMMENCES DXA AND MRI SERVICES ON NON-ALCOHOLIC FATTY LIVER DISEASE STUDY
Boston, MA, June 15, 2020 — WorldCare Clinical (WCC) a leading provider of imaging and endpoint assessment committeesfor hepatic clinical trials, today announced that it
WORLDCARE CLINICAL SAFETY COMMITTEES PROVIDE SOLUTION FOR COVID-19 VACCINE CLINICAL TRIALS
May 21, 2020 – Boston, MA WorldCare Clinical (WCC), a leading CRO focused on maximizing the precision and accuracy of independent endpoint assessments in clinical
NAVIDEA BIOPHARMACEUTICALS SIGNS LETTER OF INTENT WITH WORLDCARE CLINICAL TO PARTNER ON NAVIDEA’S RHEUMATOID ARTHRITIS CLINICAL IMAGING WORKFLOW AND COMMERCIALIZATION
DUBLIN, Ohio–(BUSINESS WIRE)– Navidea Biopharmaceuticals,Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
WORLDCARE CLINICAL EXPANDS ITS CARDIOVASCULAR SERVICES
Boston, MA, December 6, 2019 – WorldCare Clinical (WCC), a leading CRO focused on maximizingthe precision and accuracy of imaging assessments, announced its advanced quantitativecardiac
WORLDCARE CLINICAL ADVANCES RESEARCH IN BETA THALASSEMIA CLINICAL TRIALS
Boston, MA, April 19, 2019 — WorldCare Clinical (WCC), a leading provider of imaging services for clinical trials in hematological and oncological diseases, today announced
WORLDCARE CLINICAL EXPANDS ITS ONCOLOGY CLINICAL TRIAL SERVICES TO INCLUDE ASSESSMENTS OF DRUG-INDUCED CANCERS
Boston, MA, March 12, 2019 — WorldCare Clinical (WCC), aleading CRO focused on maximizing the precision and accuracy of independent endpoint assessments in clinical trials,